In previous studies performed in SMA mouse models treated with therapeutically beneficial doses of DAQ-DcpSi, SMN full length transcripts have been reported to either increase modestly [7], or not to change [8, 9]. Here, SMN1 is linked to proximal spinal muscular atrophy.